Efficacy and Safety of Alpha-2 Agonists in Autism Spectrum Disorder: A Systematic Review

期刊论文
发表日期：

2024年9月13日

查看全文

Alan D. Kaye,
Abigail M. Green,
Joseph Tremblay Claude II,
Charles P. Daniel,
Jada F. Cooley,
Kelly R. Sala,
Pooja Potharaju,
Ross Rieger,
Shilpadevi Patil,
Shahab Ahmadzadeh,
Sahar Shekoohi

摘要

Background

This analysis is a systematic literature review assessing efficacy and adverse effects of three alpha-2 agonists for the symptomatic management of autism spectrum disorder (ASD).

Methods

The present investigation involved an extensive systematic search for eligible studies in PubMed, Embase, Cochrane Library, and Google Scholar. Nine studies, collectively incorporating 226 patients, were assessed.

Results

The results demonstrated promising indications for use of alpha-2 agonists in the symptomatic management of autism spectrum disorders, including improvement of hyperactivity, impulsivity, attention deficit symptoms, irritability, and stereotypies in many of the participants studied.

Conclusion

The present investigation encourages physicians to consider treatment outcomes of clonidine, guanfacine, and lofexidine to determine the most effective management of ASD-related symptoms and to minimize adverse effects. However, our review cannot provide definitive treatment protocols related to various study limitations.